Influence factors on HBV relapse after withdrawal of nucleos(t)ide analogues treatment

被引：0
|
作者：
Zhang, Ka [1 ]
Liang, Yijia [1 ]
Sun, Xiahai [1 ]
Pan, Feixing [1 ]
Xu, Huanqi [1 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
Chronic Hepatitis B; Influence Factors; Withdrawal; Relapse;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [1] Withdrawal of Nucleos(t)ide Analogues in the Treatment of Chronic Hepatitis B: A Cornelian Choice
    Pol, Stanislas
    GASTROENTEROLOGY, 2022, 162 (03) : 698 - 699
  • [2] Nucleos(t)ide analogues causes HBV S gene mutations and carcinogenesis
    Meng-Lan Wang
    Hong Tang
    Hepatobiliary & Pancreatic Diseases International, 2016, 15 (06) : 579 - 586
  • [3] Nucleos(t)ide analogues causes HBV S gene mutations and carcinogenesis
    Wang, Meng-Lan
    Tang, Hong
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2016, 15 (06) : 579 - 586
  • [4] Treatment of chronic hepatitis B with nucleos(t)ide analogues
    Ohishi, Waka
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2012, 42 (03) : 219 - 225
  • [5] The association of the heterogeneity of HBV reverse transcriptase quasispecies with antiviral efficacy after treatment with nucleos(t)ide analogues for 10 years
    Zhou, Tai-Cheng
    Liu, Feng-Wei
    Fan, Jing-Hua
    Zhang, Si-Hang
    Lv, Song-Qin
    Yu, Zhi-Yong
    Zhang, Yan-Mei
    Zhang, Liang
    Wei, Jia
    INFECTION GENETICS AND EVOLUTION, 2021, 89
  • [6] Limited Value of HBV-RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative Hepatitis B Patients
    Ohlendorf, Valerie
    Wuebbolding, Maximilian
    zu Siederdissen, Christoph Hoener
    Bremer, Birgit
    Deterding, Katja
    Wedemeyer, Heiner
    Cornberg, Markus
    Maasoumy, Benjamin
    JOURNAL OF VIRAL HEPATITIS, 2025, 32 (04)
  • [7] PRIMARY RESISTANCE MUTATIONS AGAINST NUCLEOS(T)IDE ANALOGUES IN TREATMENT NAME PATIENTS WITH HBV-INFECTION
    Ludwig, Amei D.
    Goebel, Thomas
    Adams, Ortwin
    Baumann, Nannette
    Hauck, Katarzyna
    Fey, Holger
    Hengel, Hartmut
    Haussinger, Dieter
    Erhardt, Andreas
    HEPATOLOGY, 2008, 48 (04) : 701A - 701A
  • [8] Nucleos(t)ide Analogues can be discontinued after HBsAg Seroclearance
    Di Lellis, Maddalena Angela
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (03):
  • [9] Why and when could nucleos(t)ide analogues treatment be withdrawn?
    Lai, Jimmy Che-To
    Colombatto, Piero
    Wong, Grace Lai-Hung
    Brunetto, Maurizia Rossana
    DIGESTIVE AND LIVER DISEASE, 2025, 57 (02) : 558 - 563
  • [10] Plasma levels of HBV pregenomic RNA before and after nucleos(t)ide analogue treatment
    Jansen, Louis
    van Dort, Karel A.
    Zaaijer, Hans L.
    Kootstra, Neeltje A.
    Reesink, Hendrik W.
    HEPATOLOGY, 2013, 58 : 729A - 730A
12345